Seattle, WA, United States of America

Taylor Lehmann

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Taylor Lehmann in DNA Polymerase Variants

Introduction

Taylor Lehmann is an accomplished inventor based in Seattle, WA, known for his significant contributions to the field of biotechnology. He holds three patents, focusing primarily on recombinant DNA polymerase variants that enhance single molecule sequencing applications. His work has implications for improving the efficiency and accuracy of genetic sequencing.

Latest Patents

Lehmann's latest patents include innovative DPO4 polymerase variants. These recombinant DPO4-type DNA polymerase variants feature amino acid substitutions that modify the polymerase's properties. Such modifications lead to enhanced binding and incorporation of bulky nucleotide analog substrates into daughter strands. Additionally, the patents provide compositions comprising these DPO4 variants and nucleotide analogs, as well as nucleic acids encoding the polymerases with the aforementioned phenotypes.

Career Highlights

Throughout his career, Taylor Lehmann has worked with notable companies in the biotechnology sector, including Stratos Genomics, Inc. and Roche Sequencing Solutions, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to DNA polymerase technology.

Collaborations

Lehmann has collaborated with several professionals in his field, including Mark Stamatios Kokoris and Marc Prindle. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Taylor Lehmann's work in developing DPO4 polymerase variants represents a significant advancement in the field of genetic sequencing. His innovative contributions continue to influence the biotechnology landscape and enhance the capabilities of DNA sequencing technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…